Search Results 331-340 of 21261 for Inhibition
As a proof of concept, the team demonstrated that partial inhibition of mitochondrial complex I with CP2 blocked cognitive decline and neurodegeneration.
This study will also allow participants who are currently progressing on a Bruton tyrosine kinase inhibitor (BTKi) and requiring salvage therapy as assessed ...
... inhibitors treatments, have been unsuccessful or not well tolerated, and the patient has a GFR ≥ 45 ml/min/1.73m2, or the patient is post renal transplantation ...
... inhibitor therapy-related pneumonitis. Cancer Immunol Immunother. 2025 May 9 ... Reflections on immune checkpoint inhibition in non-small cell lung cancer.
Trandolapril is an angiotensin-converting enzyme (ACE) inhibitor. It works by blocking a substance in the body that causes blood vessels to tighten. As a ...
... inhibitors such as bortezomib or carfilzomib. Then, the team studied bone marrow biopsies from patients to further understand their results. The process ...
These are known as PDE5 inhibitors. Some supplements can cause side effects. They also can affect other medicines and health conditions. And the amount of ...
Long-term use of proton pump inhibitors, particularly at high doses, may increase your risk of hip, wrist and spine fractures. Ask your healthcare professional ...
To assess the efficacy of treatment with checkpoint inhibitors (Pembrolizumab or Nivolumab) in metastatic gastric and esophageal carcinoma through retrospective ...
Developing a new drug for women with resistance to aromatase inhibitors; Identifying mechanisms for why some people do not respond to endocrine treatment ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your gift to celebrate this day advances our doctors’ lifesaving work.